Authors : Temitope David Ogunleye; Olufisayo Idowu. Famuyiwa; Azuka Patrick. Okwuraiwe; Osasenaga Macdonald. Ighodaro; Chioma Dan-Nwafor; Elizabeth Abodunrin

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/mrhz383h

Scribd : https://tinyurl.com/3ssedxkh

DOI : https://doi.org/10.38124/ijisrt/25jul1710

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : COVID-19, caused by the newly discovered coronavirus SARS-CoV-2, is a contagious disease that has affected millions worldwide. It often begins with symptoms related to the respiratory system, such as pneumonia that affects the small air sacs and tissues in the lungs. But the virus doesn’t stop there; it can also impact other organs, including the kidneys and thyroid glands. These organs have a special receptor called ACE2, which the virus uses to enter cells, making them vulnerable. Currently, there’s limited information on how the pandemic might change kidney and thyroid health in the long run. This study aims to shed light on how the COVID-19 pandemic has affected the thyroid and kidney health of residents in Oyo State, Nigeria. We conducted a cross-sectional study focusing on individuals in Ibadan, exploring their thyroid and renal health after exposure to SARS-CoV-2. Venous blood samples were randomly collected from 165 participants in different areas of Ibadan. We gathered socio-demographic information and divided the participants into two groups: 85 individuals who were unexposed, testing negative for both SARS-CoV-2 RNA and antibodies, and 80 individuals who were exposed, testing positive for both. The renal markers (cystatin C, urea, creatinine, electrolytes) and thyroid function markers (FT3, FT4, TSH) of both groups were analyzed using an independent sample t-test. There was no significant differences (p > 0.05) found in the mean ± SD values of the identified markers between individuals exposed to SARS-CoV-2 and those unexposed. The findings suggest that individuals infected with SARS-CoV-2 in this study experienced full recovery of renal and thyroid functions during the pandemic.

Keywords : COVID-19, Renal Function Markers, SARS-CoV-2, Thyroid Function Markers.

References :

1. Koichi Y, Fujiogi M, Koutsogiannaki S. COVID-19 Pathophysiology: A review. Clinical Immunology 2020; 2: 2-3.
2. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 Infection: Origin, Transmission, and Characteristics of Human Coronaviruses. Journal of Advanced Research 2020; (24) 91.
3. Dan-Nwafor C, Ochu CL, Elimian K, Oladejo J, Ilori E, Umeokonkwo C, Steinhardt L, Igumbor E, Wagai J, Okwor T, Aderinola O, Mba N, Hassan A, Dalhat M, Jinadu K, Badaru S, Arinze C, Jafiya A, Disu Y, Saleh F, Abubakar A, Obiekea C, Yinka-Ogunleye A, Naidoo D, Nmara G, Muhammed S, Ipadeola O et al. Nigeria's Public Health Response to the COVID-19 Pandemic: January to May 2020. Journal of Global Health 2020; 10(2): 020399.
4. Bourgonje AR, Abdulle AE, Timens W, Hillebrands JI, Navis GJ, Gordijn SJ. "Angiotensin‐Converting Enzyme 2 (ACE2), SARS‐CoV‐2 and the Pathophysiology of Coronavirus Disease 2019 (COVID‐19)." Journal of Pathology 2020; 251(3): 228.
5. Lv JC, Zhang, LX Prevalence and Disease Burden of Chronic Kidney Disease, Advances in Experimental Medicine, and Biology 2019; 1165: 3–15.
6. Cheng Y, Luo R, Wang K, Zhang M, Wang. Z, Dong L, Li, J. Yao Y, Ge S, Xu G Kidney Disease Is Associated with In-Hospital Death of Patients with COVID-19. Kidney International 2020; 97: 829–838.
7. Peleg Y, Kudose S, D’Agati V, Siddall E, Ahmad S, Nickolas T, & Markowitz GS, Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Kidney International Reports 2020; 5(6): 940–945.
8. Wang M, Xiong H, Chen H, Li Q, & Ruan X, Renal Injury by SARS-CoV-2 Infection: A Systematic Review. Kidney Diseases 2021; 7(2): 100-110.
9. Ifeoma IU, Ijoma CK. The Enormity of Chronic Kidney Disease in Nigeria: The Situation in a Teaching Hospital in South-East Nigeria. Journal of Tropical Medicine 2010; 50195, 6.
10. Valerie LA, Tonelli M, Stanifer JW. The Global Burden of Kidney Disease and the Sustainable Development Goals. Bulletin of the World Health Organization 2018; 96: 414-422D.
11. Dixon T, Zachariah TS, Elamin AE, Hashim AL. Limitations of Serum Creatinine as a Marker of Renal Function. Scholars Academic Journal of Pharmacy 2017; (6)5: 168-170.
12. Olatunde O, Olabisi B. SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria. American Journal of Tropical Medicine and hygiene 2022; 104 (1): 91-94.
13. Olaleye DO, Aminu M, Olusola BA, Segun TO, Faneye AO, Opaleye AV, Odeh E, Serki M, Dairo MD, Fagbemigbe AF, Egbuna HC, Ajuwon AJ, Omilabu SA, Achi CE, Odaibo GN, Arinola OG. High Seroprevalence of SARS-CoV-2 Antibody before Covid-19 Vaccination in Nigerian Communities. International Archives Public Health and Community Medicine 2022; 6 (083): 2643-4512.
14. Kolawole OM, Tomori O, Agbonlahor D, Ekanem E, Bakare R, Abdulsalam N, Okojie O, et al, Selected Sates of High and Low Disease Burden in Nigeria, Journal of American Medical Association Network Open 2022; 5(10): e2236053
15. Valeria DG, Kamille AW, Amanda NH, Leonard NC, Sarah P. Naturally Acquired SARS-CoV-2 Immunity Persist for up to Eleven Months after Infection. Journal of Infectious Diseases 2021; 224 (8): 1294-1204.
16. Zinellu A, Mangoni AA, Cystatin C. COVID-19 Severity and Mortality: A Systematic Review and Meta Analysis. Journal of Nephrology 2022; 35(1): 59-68
17. Sidar C, Metehan B, Carlo B, Katherine T, Mehmet K. Post-Acute COVID-19 Syndrome and Kidney Disease: What Do We Know? Journal of. Nephrology 2022; 35(3): 795-80.
18. Valeria DG, Kamille AW, Amanda NH, Leonard NC, Sarah P. Naturally Acquired SARS-CoV-2 Immunity Persist for up to Eleven Months after Infection. Journal of Infectious Diseases 2021; 224 (8): 1294-1204.
19. Song HJJ, Chia AZQ, Tan BKJ, Teo CB, Lim V, Chua HR, Samuel M, Kee A. Electrolyte imbalance as Poor Prognostic Marker in COVID-19:  A Systematic Review and Meta-analysis. Journal of Endocrinological Investigation 2023; 46(2): 235-259.
20. De Carvalho H, Richard MC, Chouihed T, Goffinet N, Le Bastard Q, Freund Y, Kratz A, Dubroux M Masson D, Figueres L, Montassier E. Electrolyte Imbalance in COVID-19 Patients Admitted to the Emergency Department: A Case-Control Study. Internal and Emergency Medicine 2021; (16) 7:1945-1950.
21. Alnafiey MO, Alangari AM, Alarifi AM, Abushara A. Persistent Hypokalemia Post SARS-CoV-2 Infection: Is it a Life-Long Condition? Case report. Annals of Medicine and Surgery 2021; 62: 358-361.
22. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney Disease is Associated with In-Hospital Death of Patients with COVID-19, Kidney international 2020; 97(5): 829–838.
23. 23. Adams D, De Jonge R, Van der Cammen T, Zietse R, Hoom EJ. Acute Kidney Injury in Patients Presenting with Hyponatremia. Journal of Nephrology 2011; 24(6): 749-755.
24. Tan BWL, Tan BWQ, Tan ALM, Schriver ER, Gutierrez-Sacristan A, Das P, et al. Long-Term Kidney Function Recovery and Mortality after COVID-19-Assocoated Acute Kidney Injury: An International Multi-Centre Observation Cohort Study, eClinicalMedicine 2023; 55: 101724.
25. Kemec Z, Akgul F. Are Patients with COVID-19 at Risk of Long-Term Chronic Kidney Disease? Nigerian Journal of Clinical Practice 2023; 26 (3): 341-346.
26. Nassar A, Ibrahim IM, Amin FG, Magdy M, Elgharib AM, Azzam EB, Elfiky AA, A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses. Molecules 2021; 26 (21):  6455.
27. Jadali Z, Jadali Z. COVID-19, and Thyroid Infection: Learning the Lessons of the Past. Acta Endocrinologica (Bucharest) 2020; 16 (3): 375-376.
28. Brancatella A, Ricci D, Viola N, Sgro D, Santini F, Latrofa F, Subacute Thyroiditis after SARS-CoV-2 Infection. Journal of Clinical Endocrinol Metabolism 2020; 105, 1–4.
29. Rossetti CL, Cazarin J, Hecht F, De L Beltrão FE, Ferreira ACF, Fortunato RS, COVID-19, and Thyroid Function: What Do We Know So Far? Lausanne 2022; 13, 1041676.
30. Jiménez-Blanco S, Pla-Peris B, Marazuela M. COVID-19: A Cause of Recurrent Graves’ Hyperthyroidism? Journal of Endocrinological Investigation 2021; 44(2): 387–388.